SARS-CoV-2 tropism in the brain and its relationship to COVID-19 pathogenesis
SARS-CoV-2 tropism in the brain and its relationship to COVID-19 pathogenesis
批准号:
10272724
负责人:
ERIC D LAZARTIGUES
金额:
$64.26万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-25 至 2023-08-31
关键词:
2019-nCoVACE2AddressAdenovirus InfectionsAffectAmericanAnimal ModelAutomobile DrivingBiochemicalBrainBrain StemCOVID-19COVID-19 pandemicCOVID-19 pathogenesisCOVID-19 patientCell NucleusCessation of lifeCountryDataDeliriumDisastersDiseaseEncephalopathiesEndothelial CellsFiberFunding MechanismsHallucinationsHistologicHumanImpairmentIndividualInfectionInjectionsKnowledgeLabelLaboratoriesLeadLungLung infectionsMainstreamingMechanical ventilationMethodsMicrogliaMolecularMotor CortexMusNeurobiologyNeurogliaNeurologic SymptomsNeuronsNeurosciencesNeurotropismOrganOrganoidsPathogenesisPatientsPhotometryPneumoniaRNARecoveryRegulationReportingResearchResistanceRespirationRespiratory FailureRespiratory distressRespiratory physiologyResuscitationRiskRoleRouteSARS coronavirusSARS-CoV-2 infectionSARS-CoV-2 pathogenesisSmell PerceptionTaste PerceptionTestingTissuesTransgenic MiceTropismViral PathogenesisVirusassociated symptombetacoronaviruscell typeeffective therapyhigh rewardhigh riskin vivoinnovationinsightmental statemind controlmortalitymouse modelneuroinflammationneuron lossnovelolfactory bulboptogeneticspathogenpromoterreceptorrespiration regulationrespiratoryrespiratory virustherapeutic targetvirology
中文摘要
COVID-19是一场美国和全球灾难,已导致近100万人死亡
其中包括203,000多名美国人。COVID-19是由一部小说引起的
称为严重急性呼吸综合征(SARS)-CoV-2的β-冠状病毒(CoV),
据报道会导致严重的肺炎和致命的呼吸衰竭。之甚少
了解这种病毒的致病机理及其致病机制。在这
应用,我们建议测试SARS-CoV-2对大脑的影响。我们将开发
表达SARS-CoV-2受体的多细胞类型特异性小鼠模型,人
ACE 2,以细胞类型特异性方式。然后我们将使用各种分子,
生物化学,组织学和神经科学方法来测试大脑的向性,
SARS-CoV-2的深度及其对呼吸中枢调节的影响。
该提案将对我们目前对COVID的理解产生变革性影响-
19及其发病机制,并将揭示重要的治疗靶点。
英文摘要
COVID-19 is a US and global disaster which has led to the deaths of almost a million
individuals, including over 203,000 Americans, thus far. COVID-19 is caused by a novel
beta-coronavirus (CoV) known as Severe Acute Respiratory Syndrome (SARS)-CoV-2,
which was reported to cause severe pneumonia and lethal respiratory failure. Little is
known about the disease mechanism of this virus and its disease mechanism. In this
application, we propose to test the effects of SARS-CoV-2 on the brain. We will develop
multiple cell-type specific mouse models that express the SARS-CoV-2 receptor, human
ACE2, in a cell-type specific manner. We will then use a variety of molecular,
biochemical, histological and neuroscience approaches to test the brain tropism of
SARS-CoV-2 in depth and the effects of that on the central regulation of respiration.
This proposal will have a transformative impact on our current understanding of COVID-
19 and its mechanisms of pathogenesis and will uncover important therapeutic targets.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting ADAM17 maturation in resistant hypertension.
-
批准号:10608153
-
项目类别:
-
资助金额:$54.93万
-
财政年份:2022
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Targeting ADAM17 maturation in resistant hypertension.
-
批准号:10432585
-
项目类别:
-
资助金额:$57.83万
-
财政年份:2022
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
COVID19: SARS-CoV-2 and ACE2 interaction in hypertension
-
批准号:10152313
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
COVID19: SARS-CoV-2 and ACE2 interaction in hypertension
-
批准号:10398819
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Targeting ACE2 ubiquitination for hypertension
-
批准号:10318183
-
项目类别:
-
资助金额:$60.05万
-
财政年份:2019
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Targeting ACE2 ubiquitination for hypertension
-
批准号:10534148
-
项目类别:
-
资助金额:$60.05万
-
财政年份:2019
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
New strategies to restore ACE2 compensatory activity in neurogenic hypertension
-
批准号:10266017
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Effects of ACE2 gene therapy on Diabetes
-
批准号:7895432
-
项目类别:
-
资助金额:$20.21万
-
财政年份:2010
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Effects of ACE2 gene therapy on Diabetes
-
批准号:8102099
-
项目类别:
-
资助金额:$16.82万
-
财政年份:2010
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
P7: BRAIN-TARGETED ACE2 OVEREXPRESSION AND BLOOD PRESSURE REGULATION
-
批准号:7959748
-
项目类别:
-
资助金额:$5.55万
-
财政年份:2009
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Brain-targeted ACE2 over-expression on angiotensin-II-mediated hypertension
-
批准号:7834552
-
项目类别:
-
资助金额:$16.81万
-
财政年份:2009
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Brain-targeted ACE2 over-expression on angiotensin-II-mediated hypertension
-
批准号:8289581
-
项目类别:
-
资助金额:$35.15万
-
财政年份:2008
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Mechanisms of ACE2 Regulation in Neurogenic Hypertension
-
批准号:8772578
-
项目类别:
-
资助金额:$37.58万
-
财政年份:2008
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
P7: BRAIN-TARGETED ACE2 OVEREXPRESSION AND BLOOD PRESSURE REGULATION
-
批准号:7720715
-
项目类别:
-
资助金额:$16.93万
-
财政年份:2008
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Brain-targeted ACE2 over-expression on angiotensin-II-mediated hypertension
-
批准号:8116621
-
项目类别:
-
资助金额:$35.5万
-
财政年份:2008
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Mechanisms of ACE2 Regulation in Neurogenic Hypertension
-
批准号:9111971
-
项目类别:
-
资助金额:$37.58万
-
财政年份:2008
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Mechanisms of ACE2 Regulation in Neurogenic Hypertension
-
批准号:9269608
-
项目类别:
-
资助金额:$37.58万
-
财政年份:2008
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Brain-targeted ACE2 over-expression on angiotensin-II-mediated hypertension
-
批准号:7655265
-
项目类别:
-
资助金额:$35.5万
-
财政年份:2008
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Brain-targeted ACE2 over-expression on angiotensin-II-mediated hypertension
-
批准号:7900354
-
项目类别:
-
资助金额:$35.5万
-
财政年份:2008
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
P7: BRAIN-TARGETED ACE2 OVEREXPRESSION AND BLOOD PRESSURE REGULATION
-
批准号:7610601
-
项目类别:
-
资助金额:$20.69万
-
财政年份:2007
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ACE2/AGXT2信号轴在甲基异柳磷诱导斑马鱼神经发育异常过程中的作用机制研究
-
批准号:JCZRLH202600625
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
ACE2 Ser623磷酸化调控MED1促VSMCs功能损伤在移植血管重构中的作用及机制研究
-
批准号:2026JJ50619
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:翁春艳
-
依托单位:
AURKA介导ACE2磷酸化修饰调控内皮细胞衰老在低氧性肺动脉高压中的作用及机制研究
-
批准号:82570085
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:沈慧
-
依托单位:
牛蒡叶倍半萜成分群激活ACE2/Ang1-7/MasR轴调控血管内皮—周细胞互作促缺血性脑卒中血管正常化机制研究
-
批准号:82404910
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2024
-
负责人:郝单丽
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2细胞受体识别及其分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
ACE2通过AMPK/SIRT3调控线粒体代谢改善盐敏感性高血压肾脏纤维化的机制
-
批准号:82460087
-
项目类别:地区科学基金项目
-
资助金额:33.00万元
-
批准年份:2024
-
负责人:赵宇
-
依托单位:
铁皮石斛通过肠道 ACE2 修复 Trp/GPR142 介
导“肠-胰岛 ”轴血糖调控功能的降糖机制研
究
-
批准号:Y24H280055
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:颜美秋
-
依托单位:
人类ACE2变构抑制剂的成药性及其抗广谱冠状病毒感染的机制研究
-
批准号:82330111
-
项目类别:重点项目
-
资助金额:220万元
-
批准年份:2023
-
负责人:刘刚
-
依托单位:
CAFs来源的外泌体负性调控ACE2促进肾透明细胞癌癌栓新辅助靶向耐药的机制研究
-
批准号:82373169
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:顾良友
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2受体识别及细胞入侵机制研究
-
批准号:32300137
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈静
-
依托单位: